Medicinal – Page 159

Microfungus Podosphaera fusca and the Fungus-like Organism Peronospora ficariae as Potential Inhalant Allergens in a Mouse Model of Asthma

mycolabadmin

Researchers studied two types of plant fungi that infect common vegetables and plants to determine if they could cause asthma in mice. They found that both organisms triggered immune responses similar to those caused by known allergens, producing inflammation and asthma-like symptoms. Although their effects were weaker than the reference allergen ovalbumin, both fungi showed significant potential as respiratory allergens. This research suggests these plant parasites should be recognized as possible triggers for asthma and allergic reactions in people.

Exploring the Anticancer Potential of Coriolus versicolor in Breast Cancer: A Review

mycolabadmin

Coriolus versicolor, a medicinal mushroom known as Turkey tail in North America, contains special compounds that show promise in fighting breast cancer. Research shows these compounds can slow cancer cell growth, trigger cancer cell death through multiple pathways, prevent cancer spread, and boost the immune system’s ability to fight tumors. While early results are encouraging and the mushroom appears safe, more research is needed before it can be recommended as a standard breast cancer treatment.

Chemical Composition and Biological Activities of Psilocybe Mushrooms: Gaps and Perspectives

mycolabadmin

This review examined research on Psilocybe mushrooms and their chemical compounds, particularly psilocybin and psilocin, which show promise for treating depression and anxiety. The authors found that while these psychoactive compounds have been extensively studied, many other chemical substances in these mushrooms remain unexplored. Additionally, preliminary studies suggest these mushrooms may have antimicrobial and antioxidant properties, though more research is needed. The review highlights significant gaps in understanding the full potential of Psilocybe mushrooms for medical applications.

Chlorophyllum molybdites-synthesized manganese oxide nanoparticles (MnO-NPs): morphology, biocompatibility, and anticancer properties against liver cancer (HepG2) cell line

mycolabadmin

Researchers successfully created tiny manganese oxide particles using a wild mushroom called Chlorophyllum molybdites through an environmentally friendly process. These nanoparticles showed strong cancer-fighting ability against liver cancer cells and were effective against a parasite that causes leishmaniasis. The particles were safe for human use with minimal damage to healthy blood cells, making them promising candidates for developing new cancer and parasitic disease treatments.

Presynaptic hyperexcitability reversed by positive allosteric modulation of a GABABR epilepsy variant

mycolabadmin

Researchers studied three genetic mutations in GABA_B receptors that cause severe epilepsy and developmental problems in children. They found that these mutations prevent the receptors from reaching the cell surface and cause excessive calcium buildup in nerve terminals, leading to overexcitability. Using a special drug compound that enhances GABA_B receptor activity, the team was able to reverse these harmful effects, offering a potential new treatment strategy for affected patients.

Rediscovery of viomellein as an antibacterial compound and identification of its biosynthetic gene cluster in dermatophytes

mycolabadmin

Researchers discovered that dermatophytes, fungi that cause common skin infections like athlete’s foot, produce a red pigment called viomellein that kills bacteria. By studying the genes responsible for making this compound, scientists found that most dermatophytes produce it, which may help explain how these fungi establish infections on skin despite the presence of protective bacteria. This discovery opens new possibilities for understanding skin infections and potentially developing new treatments.

A human-relevant alternative infection model for mucormycosis using the silkworm Bombyx mori

mycolabadmin

Scientists developed a new way to test antifungal drugs using silkworms instead of expensive and ethically problematic mammal studies. They infected silkworms with mucormycosis-causing fungi and found that the infections behaved similarly to human cases, especially when they simulated human risk factors like steroid use and iron overload. The silkworm model successfully demonstrated that existing antifungal drugs work, while also revealing differences in fungal virulence that were linked to specific surface proteins.

Speciation analysis of fungi by liquid atmospheric pressure MALDI mass spectrometry

mycolabadmin

Scientists developed a fast new method using a technique called LAP-MALDI mass spectrometry to identify dangerous fungal infections within minutes instead of days. The method analyzes the unique fatty acids and proteins in fungal cells to distinguish between different species. This could help doctors quickly identify which fungal infection a patient has and choose the right treatment, potentially saving lives.

Invasive Saprochaete capitata Infection in an Immunocompromised Patient With Acute Myeloid Leukemia: A Case Report

mycolabadmin

A 46-year-old man with blood cancer developed a serious fungal infection caused by Saprochaete capitata during chemotherapy. This rare but dangerous fungus was found in his blood and lungs, causing fever and breathing problems. The patient was successfully treated with a combination of two antifungal medications and fully recovered, though this infection typically has a high death rate.

Invasive Rhinocerebral Mucormycosis Is a Rare Complication in Systemic Juvenile Idiopathic Arthritis Patient

mycolabadmin

A 5-year-old girl with a serious joint disease called systemic juvenile idiopathic arthritis developed a dangerous fungal infection in her nasal cavity and brain area. The fungal infection, caused by a mold organism called Lichtheimia, occurred because her immune system was severely weakened by medications used to treat her arthritis. Doctors treated the infection with antifungal drugs and surgery, and the patient eventually recovered by switching to a different arthritis medication. This case highlights how the strong medications needed to control some childhood arthritis can unexpectedly cause serious fungal infections.

Research Topic: Medicinal